K.Eristavi National Center of Experimental and Clinical Surgery

Tbilisi 159

2 studies enrolling now · 6 studies all time

What they study most

Acute Major Bleeding, Advanced Malignancies, CRC (Colorectal Cancer), Hematological Malignancy, Non-Transfusion Dependent Beta-Thalassemia (NTDT), Post-Essential Thrombocythemia Myelofibrosis (Post-ET-MF), Post-Polycythemia Vera Myelofibrosis (Post-PV-MF), Primary Myelofibrosis (PMF), Solid Tumor, Von Willebrand Disease (VWD)

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer — Recruiting now
• Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD) — Recruiting now
• A Study to Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent β-thalassemia, Using MRI Scans to Measure Iron Levels in the Body — Running, not enrolling
• Study of OCTAPLEX in Patients With Acute Major Bleeding on DOAC Therapy With Factor Xa Inhibitor — Stopped early
• Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies — Completed
• Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis — Status unconfirmed